Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 33.66
+9.86 (41.43%)
Aug 20, 2026, 4:09 PM HKT
Everest Medicines Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Everest Medicines stock has a consensus rating of "Buy" and an average price target of $40.73. The average 1-year stock price forecast is 21.00% higher than the current stock price, while the lowest is $25.77 (-23.44%) and the highest is $69.56 (+106.65%).
Price Target: $40.73 (+21.00%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jun 17, 2026.
Analyst Ratings
The average analyst rating for Everest Medicines stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Bank of America Securities No rating | Bank of America Securities | Hold Maintains $32.70 | Hold | Maintains | $32.70 | -2.85% | Jun 17, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $55.00 → $41.50 | Buy | Maintains | $55.00 → $41.50 | +23.29% | Jun 10, 2026 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Buy Maintains $84.00 | Buy | Maintains | $84.00 | +149.55% | Jun 9, 2026 |
Financial Forecast
Revenue This Year
3.30B
from 1.71B
Increased by 93.43%
Revenue Next Year
4.23B
from 3.30B
Increased by 28.23%
EPS This Year
0.41
from 0.56
Decreased by -26.30%
EPS Next Year
1.16
from 0.41
Increased by 182.93%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.